NSE · AI Signal & Stock Analysis · Bullish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for FDC is Bullish ↑ (moderate move); technical trend raise-2026-10-28; trading at ₹390.40 (-0.74% today); neutral (RSI 69). AkshayaAI's signal, trend and forecast for FDC have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bullish ↑ · Moderate move |
|---|---|
| Technical trend | RAISE-2026-10-28 |
| Price | ₹390.40 |
| Change today | -0.74% |
| RSI (14) | 68.70 |
| Relative volume | 1.73 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹6,058 Cr |
| P/E | 19.34 |
| Cap category | Mid Cap |
| 52-week high | -10.1% away |
| 52-week low | +21.6% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for FDC (FDC Limited) is Bullish with a moderate move, and its technical trend is raise-2026-10-28. The composite score and full factor breakdown are available to signed-in members.
FDC's RSI is neutral (RSI 69). A reading above 70 is typically overbought and below 30 oversold.
FDC is trading about 10% below its 52-week high and 22% above its 52-week low as of Nov 13 2026, 6:15 AM.
FDC's market capitalisation is ₹6,058 Cr as of Nov 13 2026, 6:15 AM.
FDC is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for FDC — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →